Æterna Zentaris Долг / собственный капитал
Что обозначает Долг / собственный капитал в Æterna Zentaris?
Долг / собственный капитал Æterna Zentaris, Inc. является 1.03
Какое определение для Долг / собственный капитал?
Соотношение долга к собственному капиталу - это финансовое соотношение, показывающее относительную пропорцию собственного капитала и долга, используемых для финансирования активов компании.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Долг / собственный капитал компаний в Health Care сектор на TSX по сравнению с Æterna Zentaris
Что делает Æterna Zentaris?
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
Компании с долг / собственный капитал похож на Æterna Zentaris
- Integra Resources имеет Долг / собственный капитал из 1.03
- Integra Resources имеет Долг / собственный капитал из 1.03
- Integra Resources имеет Долг / собственный капитал из 1.03
- California Software имеет Долг / собственный капитал из 1.03
- Braemar Shipping Services plc имеет Долг / собственный капитал из 1.03
- TCNS Clothing Co имеет Долг / собственный капитал из 1.03
- Æterna Zentaris имеет Долг / собственный капитал из 1.03
- Metro имеет Долг / собственный капитал из 1.03
- Pangaea Logistics Solutions Ltd имеет Долг / собственный капитал из 1.03
- Tassal имеет Долг / собственный капитал из 1.03
- Kerry plc имеет Долг / собственный капитал из 1.03
- Kerry plc имеет Долг / собственный капитал из 1.03
- Kerry Plc имеет Долг / собственный капитал из 1.03